COMMITTED
TO EXCEPTIONAL ACCESS
What can PREFERRED COVERAGE mean for your RA, PsA, AS, and nr‑axSpA patients?
Accessibility
Covered after trial of 1 TNFi ahead of non-preferred products.2,‡
‡Individual plan coverage/benefits may vary and are subject to change.
Affordability
Commercial:
- Lowest branded copay tier
of Commercial claims for a filled RINVOQ prescription cost patients $0–$5.3,§
§Based upon paid Commercial claims data from national data providers for a filled RINVOQ prescription for RA, PsA, AS and nr-axSpA for the period 1/2023-9/2023, inclusive of savings card redemptions.3
Patients' actual out-of-pocket cost may vary depending on their insurance coverage and eligibility for support programs.
Medicare Part D:
- Lowest coinsurance formulary tier||
||Copay assistance programs are not available to patients receiving prescription reimbursement under any federal, state or government-funded insurance programs (e.g., Medicare Part D and Medicare Advantage programs) or where prohibited by law or by the patient's health insurance provider.
*RINVOQ is on a preferred tier or otherwise has preferred status on the plan's formulary.
†Coverage requirements and benefit designs vary by payer and may change over time. Please consult with payers directly for the most current reimbursement policies.
Check the Formulary Status for RINVOQ in Your Area
Formulary Zipcode
Choose Indication
Formulary Status Results
- Plan Name
- Plan Type
- Status
Results ends here
Preferred means RINVOQ is on a preferred tier or otherwise has preferred status on the plan’s formulary.
AS=ankylosing spondylitis; nr-axSpA=non-radiographic axial spondyloarthritis; PsA=psoriatic arthritis; RA=rheumatoid arthritis; TNFi=tumor necrosis factor inhibitor.
